Effects on Septic Patient's Microcirculation of the Transfusion of Different Types of Concentrated RBCs.

May 21, 2012 updated by: Abele Donati, MD, Università Politecnica delle Marche

Effects on the Septic Patient's Microcirculation of the Transfusion of Three Different Types of Concentrated Red Blood Cells.

Aim of the study is to evaluate the effects, on microcirculation of septic patient, of three types of RBCs: 1- fresh standard RBCs (storage <10 days); 2-leukodepleted RBCs and 3-old standard RBCs (storage >15 days) respectively. Before and 1 hour after the transfusion, microcirculation is evaluated using Sidestream Dark Field Imaging (SDF) and Near InfraRed Spectroscopy (NIRS) with vascular occlusion test. We also monitor temperature, heart rate, mean blood pressure, hemochrome, blood gases, blood lactates and SOFA score.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ancona
      • Torrette di Ancona, Ancona, Italy, 60126
        • University ICU, AOU Ospedali Riuniti

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with sepsis, severe sepsis or septic shock who, according to clinical evaluation, need a hemotransfusion.

Exclusion Criteria:

  • Patients under 18 years of age; Pregnancy; Coagulative disorders; Cardiogenic shock (Met<4;)Acute massive bleeding (>8 U)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Fresh not-leukocyte-reduced RBCs
RBCs have been transfused in septic patient admitted in ICU
Active Comparator: Fresh RBCs leukocyte-reduced
RBCs have been transfused in septic patient admitted in ICU
Active Comparator: RBCs with storage longer than 15 days
RBCs have been transfused in septic patient admitted in ICU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microcirculatory Flow Index (MFI) before and after blood transfusion.
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
Microcirculatory Flow Index detected in vivo by side-dark field imaging at sublingual microcirculation. It represents the quality of blood flow at microcirculatory level. This study wants to verify any of the considered different types of blood transfused can improve MFI.
One hour after the end of blood transfusion compared with before blood transfusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perfused Vessel Density (PVD)
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
Perfused Vessel Density detected in vivo by side-dark field imaging at sublingual microcirculation. It represents the quantity of well perfused vessels at microcirculatory level. This study wants to verify any of the considered different types of blood transfused can improve PVD.
One hour after the end of blood transfusion compared with before blood transfusion
StO2 upslope
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
StO2 upslope is measured with Near InfraRed Spectroscopy at the tenar muscle. It represents the velocity of the recovery of the tissue oxygen saturation after a short period of ischemia of the hand, the Vascular Occlusion Test.
One hour after the end of blood transfusion compared with before blood transfusion
Arterial Blood Lactate
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
One hour after the end of blood transfusion compared with before blood transfusion
Arterial pH
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
One hour after the end of blood transfusion compared with before blood transfusion
SOFA score
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
One hour after the end of blood transfusion compared with before blood transfusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abele Donati, MD, Università Politecnica delle Marche

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

February 1, 2012

Study Registration Dates

First Submitted

April 23, 2012

First Submitted That Met QC Criteria

April 23, 2012

First Posted (Estimate)

April 25, 2012

Study Record Updates

Last Update Posted (Estimate)

May 23, 2012

Last Update Submitted That Met QC Criteria

May 21, 2012

Last Verified

May 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • Prot 210163

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Septic Patients

Clinical Trials on Blood transfusion

3
Subscribe